Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status:
Terminated
Trial end date:
2019-09-24
Target enrollment:
Participant gender:
Summary
Phase Ib dose escalation in advanced solid tumors to identify dose for Phase II dose
expansion in advanced or metastatic pancreatic cancer and KRAS-mutant colorectal cancer.
Open-label, nonrandomized.